{"id":2751,"date":"2016-07-19T01:36:10","date_gmt":"2016-07-19T05:36:10","guid":{"rendered":"https:\/\/globalhealthintelligence.com\/?p=2751"},"modified":"2025-12-01T13:25:07","modified_gmt":"2025-12-01T19:25:07","slug":"brazils-anvisa-updates-modification-process-lower-risk-cadastro-devices","status":"publish","type":"post","link":"https:\/\/globalhealthintelligence.com\/es\/news\/brazils-anvisa-updates-modification-process-lower-risk-cadastro-devices\/","title":{"rendered":"Brazil\u2019s ANVISA Updates Modification Process for Lower-risk Cadastro Devices"},"content":{"rendered":"<p>According to a technical note issued by ANVISA, Brazilian market participants seeking to make multiple modifications to their cadastro registrations may now submit all proposed changes to regulators using a single application form. The technical note states that ANVISA will also no longer charge a review fee for modification applications for cadastro devices.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Brazilian medical device market regulators have eased requirements for making changes to lower-risk or cadastro registrations for medical devices and IVDs.<\/p>\n","protected":false},"author":24,"featured_media":20471,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[102],"tags":[],"class_list":{"0":"post-2751","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-news"},"_links":{"self":[{"href":"https:\/\/globalhealthintelligence.com\/es\/wp-json\/wp\/v2\/posts\/2751","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/globalhealthintelligence.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/globalhealthintelligence.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/globalhealthintelligence.com\/es\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/globalhealthintelligence.com\/es\/wp-json\/wp\/v2\/comments?post=2751"}],"version-history":[{"count":1,"href":"https:\/\/globalhealthintelligence.com\/es\/wp-json\/wp\/v2\/posts\/2751\/revisions"}],"predecessor-version":[{"id":28040,"href":"https:\/\/globalhealthintelligence.com\/es\/wp-json\/wp\/v2\/posts\/2751\/revisions\/28040"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/globalhealthintelligence.com\/es\/wp-json\/wp\/v2\/media\/20471"}],"wp:attachment":[{"href":"https:\/\/globalhealthintelligence.com\/es\/wp-json\/wp\/v2\/media?parent=2751"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/globalhealthintelligence.com\/es\/wp-json\/wp\/v2\/categories?post=2751"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/globalhealthintelligence.com\/es\/wp-json\/wp\/v2\/tags?post=2751"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}